Clinical Trials
7 trialsNCT03399799 2026-06-05
MonumenTAL-1
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT04108195 2026-06-05
A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT05050097 2026-06-05
MonumenTAL-2
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT06550895 2026-06-05
MonumenTAL-8
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT06577025 2026-06-05
aMMbition
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT05455320 2026-04-13
MonumenTAL-3
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT04586426 2026-01-16
RedirecTT-1
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting